
Intelligent Medical Devices Inc., which makes technology that fights superbug infections, has pulled in $3 million from a notes and warrants sale, a company representative confirmed.
The funding comes from two separate, unnamed investors. Representatives from Intelligent Medical Devices were not available for comment.
In November 2007, Intelligent Medical Devices told Mass High Tech after years of silence it had raised a total of $15 million from angel investors to develop technology to design tests that can detect the superbug and other pathogens.
The Cambridge-based company has developed software that analyzes massive amounts of genetic code on such pathogens as the superbug to help scientists make molecular tests. In 2007, Intelligent Medical Devices CEO Alice Jacobs told Mass High Tech the company was on the hunt for corporate partners to license the technology to develop a diagnostic test for the pathogens.
Comments
If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.

Print
Email
Print Edition Stories



